Reckitt Benckiser Group plc (RBGLY) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Reckitt Benckiser Group plc (RBGLY) Consumer Business Overview

Reckitt Benckiser Group plc (RBGLY) is a global leader in consumer health, hygiene, and nutrition, distinguished by its diverse brand portfolio including Dettol, Lysol, and Durex. The company's focus on innovation and market expansion positions it strongly within the competitive household and personal products sector.

What Is the Investment Thesis for RBGLY?

The company's diverse product range provides resilience against economic cycles, while its expansion into emerging markets offers significant growth potential. With a P/E ratio of 11.32 and a profit margin of 25.2%, RBGLY demonstrates financial stability. The dividend yield of 8.58% is attractive for income-seeking investors. Ongoing catalysts include continued innovation in its core product categories and strategic acquisitions to expand its market reach. Potential risks include currency fluctuations and increasing competition from private-label brands. Investors should monitor RBGLY's ability to maintain its brand strength and adapt to changing consumer preferences.

Based on FMP financials and quantitative analysis

RBGLY Key Highlights

Market capitalization of $43.4B reflects RBGLY's significant presence in the consumer goods industry.

• Profit margin of 25.2% indicates strong operational efficiency and pricing power.
• Gross margin of 60.7% highlights the value of RBGLY's brand portfolio and product mix.
• Dividend yield of 8.58% provides an attractive income stream for investors.
• Beta of 0.10 suggests low volatility compared to the overall market.

Who Are RBGLY's Competitors?

RBGLY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are RBGLY's Key Strengths?

Strong brand recognition and customer loyalty.

• Global presence and diversified product portfolio.
• Focus on innovation and product development.
• Efficient supply chain and distribution network.

What Are RBGLY's Weaknesses?

Exposure to currency fluctuations.

• Dependence on a few key brands.
• Potential for product liability claims.
• Sensitivity to changes in consumer preferences.

What Could Drive RBGLY Stock Higher?

Continued demand for hygiene products due to increased awareness of health and safety.

• Expansion into emerging markets with growing middle-class populations.
• Launch of new innovative products in the health and nutrition segments in Q3 2026.
• Strategic acquisitions to expand product portfolio and market reach.
• Focus on sustainability initiatives to enhance brand image and attract environmentally conscious consumers.

What Are the Key Risks for RBGLY?

Inconsistent delivery — missed Wall Street EPS estimates in 4 of the last 8 reported quarters.

• Currency fluctuations impacting revenue and profitability.
• Increasing competition from private-label brands.
• Changes in regulations and consumer preferences.
• Economic downturns and reduced consumer spending.
• Disruptions in the supply chain due to geopolitical events or natural disasters.

What Are the Growth Opportunities for RBGLY?

• Expansion in Emerging Markets: RBGLY can leverage its established brands to expand its presence in high-growth emerging markets like China and India. These markets offer significant opportunities due to increasing disposable incomes and growing demand for health and hygiene products. The emerging markets contribute over 30% of RBGLY's revenue, with a target to increase this to 40% by 2030.
• Product Innovation: Investing in research and development to launch innovative products in its core categories can drive organic growth. RBGLY can focus on developing sustainable and eco-friendly products to cater to environmentally conscious consumers. The company allocates approximately 3% of its revenue to R&D, with a focus on developing new formulations and packaging solutions.
• Strategic Acquisitions: Acquiring complementary brands and businesses can expand RBGLY's product portfolio and geographic reach. The company can target acquisitions in high-growth segments like vitamins, minerals, and supplements (VMS). RBGLY has a track record of successful acquisitions, including the acquisition of Mead Johnson Nutrition in 2017, which strengthened its position in the infant nutrition market.
• E-commerce Growth: Focusing on expanding its online presence and e-commerce capabilities can drive sales and improve customer engagement. RBGLY can invest in digital marketing and partnerships with e-commerce platforms to reach a wider audience. E-commerce currently accounts for approximately 15% of RBGLY's revenue, with a target to increase this to 25% by 2028.
• Sustainability Initiatives: Implementing sustainable practices and reducing its environmental footprint can enhance RBGLY's brand image and attract environmentally conscious consumers. The company can focus on reducing its carbon emissions, using sustainable packaging materials, and promoting responsible consumption. RBGLY has committed to reducing its carbon emissions by 50% by 2030 and using 100% recyclable packaging by 2025.

What Are RBGLY's Competitive Advantages?

• Strong brand portfolio with well-known and trusted brands like Dettol, Lysol, and Durex.
• Global presence with operations in numerous countries, providing diversification and access to different markets.
• Focus on innovation and product development, allowing the company to stay ahead of competitors and meet evolving consumer needs.
• Efficient supply chain and distribution network, ensuring products are available to customers in a timely and cost-effective manner.

What Does RBGLY Do?

Reckitt Benckiser Group plc, founded in 1819 and headquartered in Slough, United Kingdom, is a multinational consumer goods company focused on health, hygiene, and nutrition. The company's evolution from a starch manufacturer to a global powerhouse reflects its ability to adapt to changing consumer needs and market dynamics. RBGLY's product portfolio is organized into key segments, including hygiene, health, and nutrition. Its hygiene products, marketed under brands like Dettol and Lysol, focus on disinfection and cleaning. The health segment includes brands like Nurofen, Strepsils, and Mucinex, offering solutions for pain relief, sore throat, and cough and cold. The nutrition segment, anchored by brands like Enfamil and Nutramigen, provides infant and toddler nutrition products. RBGLY operates in numerous countries, with a significant presence in the United Kingdom, the United States, China, and India. The company competes with other major players in the consumer goods industry, emphasizing innovation, brand strength, and operational efficiency to maintain its market position.

What Products and Services Does RBGLY Offer?

• Manufactures and sells health, hygiene, and nutrition products.
• Offers disinfection and hygiene products under the Dettol and Lysol brands.
• Provides pain relief and cold and flu remedies under the Nurofen and Mucinex brands.
• Markets infant and toddler nutrition products under the Enfamil and Nutramigen brands.
• Sells condoms, sex toys, and lubricants under the Durex brand.
• Offers home cleaning products under the Finish and Harpic brands.
• Provides vitamins, minerals, and supplements under the Airborne and Move Free brands.

How Does RBGLY Make Money?

• Develops, manufactures, and markets a wide range of consumer health, hygiene, and nutrition products.
• Distributes products through various channels, including retail stores, pharmacies, and e-commerce platforms.
• Invests in brand building and marketing to create strong brand recognition and customer loyalty.
• Focuses on innovation and product development to meet evolving consumer needs.

What Industry Does RBGLY Operate In?

Reckitt Benckiser Group plc operates in the competitive household and personal products industry, which is characterized by evolving consumer preferences and increasing demand for health and hygiene products. The global market for household and personal care products is estimated at over $500 billion, with a projected growth rate of 3-5% annually. RBGLY competes with major players like DANOY (Danone), DGEAF (Diageo), GPDNF (Grupo Nutresa), HEINY (Heineken), and HELKF (Haleon). The company's focus on innovation, brand building, and strategic acquisitions positions it to capitalize on market trends and maintain its competitive edge.

Who Are RBGLY's Key Customers?

• Consumers seeking health and hygiene products for personal and household use.
• Parents looking for infant and toddler nutrition products.
• Individuals seeking pain relief and cold and flu remedies.
• Retailers and pharmacies that sell RBGLY's products to consumers.

Company Profile

Reckitt Benckiser Group plc operates in the Household & Personal Products industry within the Consumer Defensive sector. It is headquartered in Slough, GB. The company is led by CEO Kris Licht. RBGLY has traded publicly since 2008.

Reckitt Benckiser Group plc Financial Trajectory

Reckitt Benckiser Group plc (RBGLY) reported $8.73B in revenue for Q2 FY2026, a decline of 10.0% compared to the prior quarter. The company recorded net income of $888.0M, with diluted EPS of $0.27. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Consumer Defensive. Across the four most recent quarters, RBGLY averaged $0.42 in diluted EPS.

How Reckitt Benckiser Group plc Is Valued

Reckitt Benckiser Group plc carries a market capitalization of $43.4B, placing it in the large-cap category. Relative to its peer group, RBGLY's quantitative score of 48/100 is roughly in line with the peer average of 54/100.

Return on equity for Reckitt Benckiser Group plc stands at 45.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 12.7%, showing how much profit it generates from its asset base. RBGLY trades at a trailing price-to-earnings ratio of 11.32, below the Consumer Defensive sector average of ~27.60x. Its free cash flow yield is 4.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.85 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 10.2%, the inverse of the P/E and a quick read on earnings relative to price.

Reckitt Benckiser Group plc's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.24 places it in the safe zone, indicating low near-term bankruptcy risk.

Reckitt Benckiser Group plc has missed Wall Street's EPS estimate in 4 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 5.5% below estimates on average.

RBGLY Financials

RBGLY Latest News

RBGLY Analyst Consensus

RBGLY MoonshotScore

Common Questions About RBGLY (Consumer Defensive)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources